Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease
Streptococcus pneumoniae, the main cause of community-acquired pneumonia (CAP), also leads to exacerbations, hospitalizations, and mortality in chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). The risk of CAP is increased in patients with diabetes mellitus (DM), and t...
Main Authors: | Aude Kopp, Olivier Mangin, Laurène Gantzer, Béranger Lekens, Guy Simoneau, Manoro Ravelomanantsoa, John Evans, Jean-François Bergmann, Pierre Sellier |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1756669 |
Similar Items
-
A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
by: Marta Moreira, et al.
Published: (2017-06-01) -
Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice
by: Oliver Frank, et al.
Published: (2020-04-01) -
Changes in the use of psychotropic drugs during the course of Alzheimer's disease: A large‐scale longitudinal study of French medical records
by: Manon Ansart, et al.
Published: (2021-01-01) -
Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018
by: Gulsen Hascelik, et al.
Published: (2023-12-01) -
Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review
by: Francesca Rosamilia, et al.
Published: (2021-11-01)